KM
KATZ MICHAEL W Dirigeant
Other M
US US · SEC (Form 4)
€400,670
▲ Purchases (13 ops.)
Explore the complete record of transactions filed by KATZ MICHAEL W, Dirigeant. Director active across 1 companies, notably Organogenesis Holdings Inc.. Aggregated, 13 disclosures have been logged. Total volume traded: €401k. The latest transaction was filed on 16 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations 13 total
€22,934 4,000 shares @ €5.7335 0.0035% mcap 5.7% of flow
Class A Common Stock
SEC:0001062993-22-012917:0 · 16 May 2022
Ideal exit: 10 Feb 2023 (T+270) €4,265 500 shares @ €8.5309 0.0006% mcap 2.3% of flow
Class A Common Stock
SEC:0001062993-21-012871 · 13 Dec 2021
Ideal exit: 9 Sept 2022 (T+270) €4,265 500 shares @ €8.5309 0.0006% mcap 1.1% of flow
Class A Common Stock
SEC:0001062993-21-012871:0 · 13 Dec 2021
Ideal exit: 9 Sept 2022 (T+270) €8,613 1,000 shares @ €8.6134 0.0013% mcap 4.6% of flow
Class A Common Stock
SEC:0001062993-21-012263 · 2 Dec 2021
Ideal exit: 29 Aug 2022 (T+270) €8,613 1,000 shares @ €8.6134 0.0013% mcap 2.1% of flow
Class A Common Stock
SEC:0001062993-21-012263:0 · 2 Dec 2021
Ideal exit: 29 Aug 2022 (T+270) €8,634 1,000 shares @ €8.6335 0.0013% mcap 4.6% of flow
Class A Common Stock
SEC:0001062993-21-011910 · 29 Nov 2021
Ideal exit: 26 Aug 2022 (T+270) €8,634 1,000 shares @ €8.6335 0.0013% mcap 2.2% of flow
Class A Common Stock
SEC:0001062993-21-011910:0 · 29 Nov 2021
Ideal exit: 26 Aug 2022 (T+270) €8,760 1,000 shares @ €8.7603 0.0013% mcap 4.6% of flow
Class A Common Stock
SEC:0001062993-21-011825 · 26 Nov 2021
Ideal exit: 23 Aug 2022 (T+270) €8,760 1,000 shares @ €8.7603 0.0013% mcap 2.2% of flow
Class A Common Stock
SEC:0001062993-21-011825:0 · 26 Nov 2021
Ideal exit: 23 Aug 2022 (T+270) €19,737 2,000 shares @ €9.8683 0.0030% mcap 10.4% of flow
Class A Common Stock
SEC:0001661181-21-000071 · 12 Nov 2021
Ideal exit: 9 Aug 2022 (T+270) €19,737 2,000 shares @ €9.8683 0.0030% mcap 4.9% of flow
Class A Common Stock
SEC:0001661181-21-000071:0 · 12 Nov 2021
Ideal exit: 9 Aug 2022 (T+270) €138,859 12,000 shares @ €11.5716 0.021% mcap 73.5% of flow
Class A Common Stock
SEC:0001661181-21-000066 · 17 Aug 2021
Ideal exit: 14 May 2022 (T+270) €138,859 12,000 shares @ €11.5716 0.021% mcap 34.7% of flow
Class A Common Stock
SEC:0001661181-21-000066:0 · 17 Aug 2021
Ideal exit: 14 May 2022 (T+270) About KATZ MICHAEL W KATZ MICHAEL W is an executive at Organogenesis Holdings Inc. In this role, he contributes to managing the company's operations and implementing its strategy. His expertise is valuable for supporting Organogenesis Holdings Inc.'s initiatives.